Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: A Systematic Review

Cheng Chia Lee, Daniel M. Trifiletti, Arjun Sahgal, Antonio DeSalles, Laura Fariselli, Motohiro Hayashi, Marc Levivier, Lijun Ma, Roberto Martínez Álvarez, Ian Paddick, Jean Regis, Samuel Ryu, Ben Slotman, Jason Sheehan

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Stereotactic radiosurgery (SRS) has become popular as a standard treatment for cavernous sinus (CS) meningiomas. OBJECTIVE: To summarize the published literature specific to the treatment of CS meningioma with SRS found through a systematic review, and to create recommendations on behalf of the International Stereotactic Radiosurgery Society. METHODS: Articles published from January 1963 to December 2014 were systemically reviewed. Three electronic databases, PubMed, EMBASE, and The Cochrane Central Register of Controlled Trials, were searched. Publications in English with at least 10 patients (each arm) were included. RESULTS: Of 569 screened abstracts, a total of 49 full-text articles were included in the analysis. All studies were retrospective. Most of the reports had favorable outcomes with 5-yr progression-free survival (PFS) rates ranging from 86% to 99%, and 10-yr PFS rates ranging from 69% to 97%. The post-SRS neurological preservation rate ranged from 80% to 100%. Resection can be considered for the treatment of larger (>3 cm in diameter) and symptomatic CS meningioma in patients both receptive to and medically eligible for open surgery. Adjuvant or salvage SRS for residual or recurrent tumor can be utilized depending on factors such as tumor volume and proximity to adjacent critical organs at risk. CONCLUSION: The literature is limited to level III evidence with respect to outcomes of SRS in patients with CS meningioma. Based on the observed results, SRS offers a favorable benefit to risk profile for patients with CS meningioma.

Original languageEnglish
Pages (from-to)1128-1142
Number of pages15
JournalNeurosurgery
Volume83
Issue number6
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Cavernous Sinus
Radiosurgery
Meningioma
Practice Guidelines
Disease-Free Survival
Survival Rate
Organs at Risk
Tumor Burden
PubMed
Publications
Arm
Therapeutics
Retrospective Studies
Databases

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline : A Systematic Review. / Lee, Cheng Chia; Trifiletti, Daniel M.; Sahgal, Arjun; DeSalles, Antonio; Fariselli, Laura; Hayashi, Motohiro; Levivier, Marc; Ma, Lijun; Álvarez, Roberto Martínez; Paddick, Ian; Regis, Jean; Ryu, Samuel; Slotman, Ben; Sheehan, Jason.

In: Neurosurgery, Vol. 83, No. 6, 01.12.2018, p. 1128-1142.

Research output: Contribution to journalArticle

Lee, CC, Trifiletti, DM, Sahgal, A, DeSalles, A, Fariselli, L, Hayashi, M, Levivier, M, Ma, L, Álvarez, RM, Paddick, I, Regis, J, Ryu, S, Slotman, B & Sheehan, J 2018, 'Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: A Systematic Review', Neurosurgery, vol. 83, no. 6, pp. 1128-1142. https://doi.org/10.1093/neuros/nyy009
Lee, Cheng Chia ; Trifiletti, Daniel M. ; Sahgal, Arjun ; DeSalles, Antonio ; Fariselli, Laura ; Hayashi, Motohiro ; Levivier, Marc ; Ma, Lijun ; Álvarez, Roberto Martínez ; Paddick, Ian ; Regis, Jean ; Ryu, Samuel ; Slotman, Ben ; Sheehan, Jason. / Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline : A Systematic Review. In: Neurosurgery. 2018 ; Vol. 83, No. 6. pp. 1128-1142.
@article{5fc79fda1a9a467494f2d301100e4c83,
title = "Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: A Systematic Review",
abstract = "BACKGROUND: Stereotactic radiosurgery (SRS) has become popular as a standard treatment for cavernous sinus (CS) meningiomas. OBJECTIVE: To summarize the published literature specific to the treatment of CS meningioma with SRS found through a systematic review, and to create recommendations on behalf of the International Stereotactic Radiosurgery Society. METHODS: Articles published from January 1963 to December 2014 were systemically reviewed. Three electronic databases, PubMed, EMBASE, and The Cochrane Central Register of Controlled Trials, were searched. Publications in English with at least 10 patients (each arm) were included. RESULTS: Of 569 screened abstracts, a total of 49 full-text articles were included in the analysis. All studies were retrospective. Most of the reports had favorable outcomes with 5-yr progression-free survival (PFS) rates ranging from 86{\%} to 99{\%}, and 10-yr PFS rates ranging from 69{\%} to 97{\%}. The post-SRS neurological preservation rate ranged from 80{\%} to 100{\%}. Resection can be considered for the treatment of larger (>3 cm in diameter) and symptomatic CS meningioma in patients both receptive to and medically eligible for open surgery. Adjuvant or salvage SRS for residual or recurrent tumor can be utilized depending on factors such as tumor volume and proximity to adjacent critical organs at risk. CONCLUSION: The literature is limited to level III evidence with respect to outcomes of SRS in patients with CS meningioma. Based on the observed results, SRS offers a favorable benefit to risk profile for patients with CS meningioma.",
author = "Lee, {Cheng Chia} and Trifiletti, {Daniel M.} and Arjun Sahgal and Antonio DeSalles and Laura Fariselli and Motohiro Hayashi and Marc Levivier and Lijun Ma and {\'A}lvarez, {Roberto Mart{\'i}nez} and Ian Paddick and Jean Regis and Samuel Ryu and Ben Slotman and Jason Sheehan",
year = "2018",
month = "12",
day = "1",
doi = "10.1093/neuros/nyy009",
language = "English",
volume = "83",
pages = "1128--1142",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline

T2 - A Systematic Review

AU - Lee, Cheng Chia

AU - Trifiletti, Daniel M.

AU - Sahgal, Arjun

AU - DeSalles, Antonio

AU - Fariselli, Laura

AU - Hayashi, Motohiro

AU - Levivier, Marc

AU - Ma, Lijun

AU - Álvarez, Roberto Martínez

AU - Paddick, Ian

AU - Regis, Jean

AU - Ryu, Samuel

AU - Slotman, Ben

AU - Sheehan, Jason

PY - 2018/12/1

Y1 - 2018/12/1

N2 - BACKGROUND: Stereotactic radiosurgery (SRS) has become popular as a standard treatment for cavernous sinus (CS) meningiomas. OBJECTIVE: To summarize the published literature specific to the treatment of CS meningioma with SRS found through a systematic review, and to create recommendations on behalf of the International Stereotactic Radiosurgery Society. METHODS: Articles published from January 1963 to December 2014 were systemically reviewed. Three electronic databases, PubMed, EMBASE, and The Cochrane Central Register of Controlled Trials, were searched. Publications in English with at least 10 patients (each arm) were included. RESULTS: Of 569 screened abstracts, a total of 49 full-text articles were included in the analysis. All studies were retrospective. Most of the reports had favorable outcomes with 5-yr progression-free survival (PFS) rates ranging from 86% to 99%, and 10-yr PFS rates ranging from 69% to 97%. The post-SRS neurological preservation rate ranged from 80% to 100%. Resection can be considered for the treatment of larger (>3 cm in diameter) and symptomatic CS meningioma in patients both receptive to and medically eligible for open surgery. Adjuvant or salvage SRS for residual or recurrent tumor can be utilized depending on factors such as tumor volume and proximity to adjacent critical organs at risk. CONCLUSION: The literature is limited to level III evidence with respect to outcomes of SRS in patients with CS meningioma. Based on the observed results, SRS offers a favorable benefit to risk profile for patients with CS meningioma.

AB - BACKGROUND: Stereotactic radiosurgery (SRS) has become popular as a standard treatment for cavernous sinus (CS) meningiomas. OBJECTIVE: To summarize the published literature specific to the treatment of CS meningioma with SRS found through a systematic review, and to create recommendations on behalf of the International Stereotactic Radiosurgery Society. METHODS: Articles published from January 1963 to December 2014 were systemically reviewed. Three electronic databases, PubMed, EMBASE, and The Cochrane Central Register of Controlled Trials, were searched. Publications in English with at least 10 patients (each arm) were included. RESULTS: Of 569 screened abstracts, a total of 49 full-text articles were included in the analysis. All studies were retrospective. Most of the reports had favorable outcomes with 5-yr progression-free survival (PFS) rates ranging from 86% to 99%, and 10-yr PFS rates ranging from 69% to 97%. The post-SRS neurological preservation rate ranged from 80% to 100%. Resection can be considered for the treatment of larger (>3 cm in diameter) and symptomatic CS meningioma in patients both receptive to and medically eligible for open surgery. Adjuvant or salvage SRS for residual or recurrent tumor can be utilized depending on factors such as tumor volume and proximity to adjacent critical organs at risk. CONCLUSION: The literature is limited to level III evidence with respect to outcomes of SRS in patients with CS meningioma. Based on the observed results, SRS offers a favorable benefit to risk profile for patients with CS meningioma.

UR - http://www.scopus.com/inward/record.url?scp=85051803020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051803020&partnerID=8YFLogxK

U2 - 10.1093/neuros/nyy009

DO - 10.1093/neuros/nyy009

M3 - Article

C2 - 29554317

AN - SCOPUS:85051803020

VL - 83

SP - 1128

EP - 1142

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 6

ER -